STAT3 and metabolic dysfunction-associated steatohepatitis: STAT1 and STAT2 have been shown to inhibit HCV replication after being activated by IFNs [12], while activation of STAT1 and STAT3 are found in non-alcoholic steatohepatitis (NASH) [13].